Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Othman Mohammad Saleh, Khaled Anwer Albakri, Yasmeen Jamal Alabdallat, Majd Hamdi Dajani & Walaa Bayoumie El Gazzar. (2022) The safety and efficacy of CAR-T cells in the treatment of prostate cancer: review. Biomarkers 27:1, pages 22-34.
Read now
Read now
Mirkomil Sharipov, Shavkatjon Azizov, Sarvar Kakhkhorov, Akhmadkhodja Yunuskhodjaev & Yong-Ill Lee. (2019) Emerging spectroscopic techniques for prostate cancer diagnosis. Applied Spectroscopy Reviews 54:10, pages 829-855.
Read now
Read now
Sheeba Alam & Douglas G McNeel. (2010) DNA vaccines for the treatment of prostate cancer. Expert Review of Vaccines 9:7, pages 731-745.
Read now
Read now
Mayer Fishman. (2009) A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer. Expert Opinion on Biological Therapy 9:12, pages 1565-1575.
Read now
Read now
Articles from other publishers (35)
Heming Zhao, Liming Gong, Hao Wu, Chao Liu, Yanhong Liu, Congcong Xiao, Chenfei Liu, Liqing Chen, Mingji Jin, Zhonggao Gao, Youyan Guan & Wei Huang. (2023) Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells. Pharmaceutics 15:7, pages 1874.
Crossref
Crossref
Qiaomiao Lu, Yu Long, Yongkang Gai, Qingyao Liu, Dawei Jiang & Xiaoli Lan. (2023) [177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy. European Journal of Nuclear Medicine and Molecular Imaging 50:8, pages 2342-2352.
Crossref
Crossref
Bently P. Doonan, Shereen Amria, Jennifer R. Bethard, Narendra L. Banik, Jessica D. Hathaway-Schrader & Azizul Haque. (2022) Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer Cells. International Journal of Molecular Sciences 23:23, pages 15234.
Crossref
Crossref
Qiaomiao Lu, Yu Long, Kevin Fan, Zhiwen Shen, Yongkang Gai, Qingyao Liu, Dawei Jiang, Weibo Cai, Chidan Wan & Xiaoli Lan. (2022) PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617. European Journal of Nuclear Medicine and Molecular Imaging 49:12, pages 4000-4013.
Crossref
Crossref
Sashi Debnath, Guiyang Hao, Bing Guan, Pawan Thapa, Justin Hao, Hans Hammers & Xiankai Sun. (2022) Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists. International Journal of Molecular Sciences 23:13, pages 7160.
Crossref
Crossref
Selvaraj Kunjiappan, Parasuraman Pavadai, Sivakumar Vellaichamy, Sureshbabu Ram Kumar Pandian, Vigneshwaran Ravishankar, Ponnusamy Palanisamy, Saravanan Govindaraj, Gowshiki Srinivasan, Adhvitha Premanand, Murugesan Sankaranarayanan & Panneerselvam Theivendren. (2020) Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review. Drug Development Research 82:3, pages 309-340.
Crossref
Crossref
Joseph A. O’Donoghue, Daniel C. Danila, Neeta Pandit-Taskar, Volkan Beylergil, Sarah M. Cheal, Stephen E. Fleming, Josef J. Fox, Shutian Ruan, Pat B. Zanzonico, Govind Ragupathi, Serge K. Lyashchenko, Simon P. Williams, Howard I. Scher, Bernard M. Fine, John L. Humm, Steven M. Larson, Michael J. Morris & Jorge A. Carrasquillo. (2019)
Pharmacokinetics and Biodistribution of a [
89
Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients
. Molecular Pharmaceutics 16:7, pages 3083-3090.
Crossref
Crossref
Dian JiaoYu LiFa YangDonghui HanJieheng WuShengjia ShiFeng TianZhangyan GuoWenjin XiGuodong LiAizhi ZhaoAn-Gang YangWeijun QinHe WangWeihong Wen. (2019) Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma. Clinical and Translational Gastroenterology 10:5, pages e00041.
Crossref
Crossref
Matthew Dowling, Jonathan Samuelson, Bahaa Fadl-Alla, Holly C. Pondenis, Mark Byrum, Anne M. Barger & Timothy M. Fan. (2019) Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions. PLOS ONE 14:1, pages e0210297.
Crossref
Crossref
Alla G. Wernicke, Sae Kim, He Liu, Neil H. Bander & Edyta C. Pirog. (2017) Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy. Applied Immunohistochemistry & Molecular Morphology 25:4, pages 271-276.
Crossref
Crossref
Christian Foster, Andre Watson, Joseph Kaplinsky & Nazila Kamaly. 2017. Cancer Nanotechnology. Cancer Nanotechnology
13
37
.
Nazila Kamaly, Basit Yameen, Jun Wu & Omid C. Farokhzad. (2016) Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chemical Reviews 116:4, pages 2602-2663.
Crossref
Crossref
Bomy Lee Chung, Michael J. Toth, Nazila Kamaly, Yoshitaka J. Sei, Jacob Becraft, Willem J.M. Mulder, Zahi A. Fayad, Omid C. Farokhzad, YongTae Kim & Robert Langer. (2015) Nanomedicines for endothelial disorders. Nano Today 10:6, pages 759-776.
Crossref
Crossref
Yajie Gao, Chao Zhang, Yanxia Zhou, Jinwen Li, Lei Zhao, Yushu Li, Yan Liu & Xinru Li. (2015) Endosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel. Pharmaceutical Research.
Crossref
Crossref
Yajie Gao, Yanfang Li, Yushu Li, Lan Yuan, Yanxia Zhou, Jinwen Li, Lei Zhao, Chao Zhang, Xinru Li & Yan Liu. (2015) PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking. Nanoscale 7:2, pages 597-612.
Crossref
Crossref
Mona Abdel-Hadi, Yasser Ismail & Layla Younis. (2014) Prostate-specific membrane antigen (PSMA) immunoexpression in the neovasculature of colorectal carcinoma in Egyptian patients. Pathology - Research and Practice 210:11, pages 759-763.
Crossref
Crossref
Alla Gabriella Wernicke, Sonal Varma, Eleni A. Greenwood, Paul J. Christos, K. S. Clifford Chao, He Liu, Neil H. Bander & Sandra J. Shin. (2014) Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. APMIS 122:6, pages 482-489.
Crossref
Crossref
Hamed Zare, Masoumeh Rajabibazl, Iraj Rasooli, Walead Ebrahimizadeh, Hamid Bakherad, Leila Safaiee Ardakani & Seyed Latif Mousavi Gargari. (2014) Production of Nanobodies against Prostate-Specific Membrane Antigen (PSMA) Recognizing LnCaP Cells. The International Journal of Biological Markers 29:2, pages 169-179.
Crossref
Crossref
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly & Omid C. Farokhzad. (2014) Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews 66, pages 2-25.
Crossref
Crossref
Jing Xu, Jingmou Yu, Xiao Xu, Liangliang Wang, Yonghua Liu, Lixin Li, Jianguo Zhao & Ming He. (2014) Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy. Journal of Nanomaterials 2014, pages 1-13.
Crossref
Crossref
Monireh Mohsenzadegan, Zahra Madjd, Mojgan Asgari, Maryam Abolhasani, Mehdi Shekarabi, Jaleh Taeb & Ahmad Shariftabrizi. (2013) Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. Cancer Immunology, Immunotherapy 62:10, pages 1609-1618.
Crossref
Crossref
Fayun Zhang, Liang Shan, Yuanyi Liu, David Neville, Jung-Hee Woo, Yue Chen, Alexandru Korotcov, Stephen Lin, Sophia Huang, Rajagopalan Sridhar, Wei Liang & Paul C. Wang. (2013) An Anti-PSMA Bivalent Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Imaging and Therapy. Advanced Healthcare Materials 2:5, pages 736-744.
Crossref
Crossref
Hung-Wei YangMu-Yi HuaHao-Li LiuRung-Ywan TsaiCheng-Keng ChuangPo-Chun ChuPei-Yi WuYing-Hsu ChangHeng-Chang ChuangKai-Jie YuSee-Tong Pang. (2012) Cooperative Dual-Activity Targeted Nanomedicine for Specific and Effective Prostate Cancer Therapy. ACS Nano 6:2, pages 1795-1805.
Crossref
Crossref
Nazila Kamaly, Zeyu Xiao, Pedro M. Valencia, Aleksandar F. Radovic-Moreno & Omid C. Farokhzad. (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chemical Society Reviews 41:7, pages 2971.
Crossref
Crossref
Zhiyong Qiu, David C. Diamond, Kent A. Smith, Dar Rosario, Sabrina Miles, Mihail Obrocea, Thomas M. Kundig & Adrian Bot. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice
103
125
.
Xiao-ling Yang, Jing Lv, Yue-hong Zhang & Bo Niu. (2011) Anti-tumor efficacy of gene vaccine expressing PSMA. Clinical Oncology and Cancer Research 7:6, pages 347-351.
Crossref
Crossref
Vittore Cereda, Diane J. Poole, Claudia Palena, Sudipto Das, Tapan K. Bera, Cinzia Remondo, James L. Gulley, Philip M. Arlen, Junko Yokokawa, Ira Pastan, Jeffrey Schlom & Kwong Y. Tsang. (2009) New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunology, Immunotherapy 59:1, pages 63-71.
Crossref
Crossref
Ryan P. Murelli, Andrew X. Zhang, Julien Michel, William L. Jorgensen & David A. Spiegel. (2009) Chemical Control over Immune Recognition: A Class of Antibody-Recruiting Small Molecules That Target Prostate Cancer. Journal of the American Chemical Society 131:47, pages 17090-17092.
Crossref
Crossref
Michael C. Haffner, Irmgard E. Kronberger, Jeffrey S. Ross, Christine E. Sheehan, Matthias Zitt, Gilbert Mühlmann, Dietmar Öfner, Bettina Zelger, Christian Ensinger, Ximing J. Yang, Stephan Geley, Raimund Margreiter & Neil H. Bander. (2009) Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Human Pathology 40:12, pages 1754-1761.
Crossref
Crossref
Tiancheng Liu, Lisa Y. Wu, Joseph K. Choi & Clifford E. Berkman. (2009) In vitro targeted photodynamic therapy with a pyropheophorbide‐a conjugated inhibitor of prostate‐specific membrane antigen. The Prostate 69:6, pages 585-594.
Crossref
Crossref
Hikmat A Al-Ahmadie, Semra Olgac, Polly D Gregor, Satish K Tickoo, Samson W Fine, G Varuni Kondagunta, Howard I Scher, Michael J Morris, Paul Russo, Robert J Motzer & Victor E Reuter. (2008) Expression of prostate-specific membrane antigen in renal cortical tumors. Modern Pathology 21:6, pages 727-732.
Crossref
Crossref
S. Perner, K.D. Mertz, R. Kuefer & M.A. Rubin. (2007) Biomarker beim ProstatakarzinomBiomarkers for prostate cancer. Der Onkologe 13:8, pages 669-676.
Crossref
Crossref
Robert J. Durso, Sofija Andjelic, Jason P. Gardner, Dennis J. Margitich, Gerald P. Donovan, Robert R. Arrigale, Xinning Wang, Maureen F. Maughan, Todd L. Talarico, Robert A. Olmsted, Warren D.W. Heston, Paul J. Maddon & William C. Olson. (2007) A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses. Clinical Cancer Research 13:13, pages 3999-4008.
Crossref
Crossref
Omid C. FarokhzadJianjun ChengBenjamin A. TeplyInes SherifiSangyong Jon, Philip W. Kantoff, Jerome P. RichieRobert Langer. (2006)
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy
in vivo
. Proceedings of the National Academy of Sciences 103:16, pages 6315-6320.
Crossref
Crossref
Ted C. Chu, Felice Shieh, Laura A. Lavery, Matthew Levy, Rebecca Richards-Kortum, Brian A. Korgel & Andrew D. Ellington. (2006) Labeling tumor cells with fluorescent nanocrystal–aptamer bioconjugates. Biosensors and Bioelectronics 21:10, pages 1859-1866.
Crossref
Crossref